Tag Archives | SciClone Pharmaceuticals

SciClone Pharmaceuticals Proxy Voting Guide

SciClone Pharmaceuticals Proxy Voting Guide by CorpGov.net. SciClone Pharmaceuticals, Inc. (SCLN), a specialty pharmaceutical company, provides therapies for oncology, infectious diseases, and cardiovascular disorders in the People’s Republic of China, the United States. SciClone Pharmaceuticals is one of the stocks in my portfolio. ProxyDemocracy.org had collected the votes of no fund families when I checked and voted. Their annual meeting is coming up on June 8, 2017.SciClone Pharmaceuticals

SciClone PharmaceuticalsI voted FOR #5 proxy access, proposed by me, James McRitchie. See how and why I voted this and other items below. I voted with the Board’s recommendations 80% of the time. View proxy via SEC’s EDGAR system (look for DEF 14A).

Read Warnings below. What follows are my recommendations on how to vote the proxy in order to enhance corporate governance and long-term value. Continue Reading →

Continue Reading ·

SciClone Pharmaceuticals – Proxy Access

SciClone PharmaceuticalsSciClone Pharmaceuticals, Inc. (NASD:SCLN), whose product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders. Their annual meeting is coming up on June 9, 2016.

ProxyDemocracy.org had collected the votes of one fund family when I checked. Vote AGAINST pay, committee chair; FOR proxy access proposal. I voted with the Board’s recommendations 70% of the time. View Proxy Statement via iiWisdom. Continue Reading →

Continue Reading ·

SciClone Pharmaceuticals: Proxy Score 78

SciClone PharmaceuticalsSciClone Pharmaceuticals, Inc. (NASD:SCLN) is one of the stocks in my portfolio. Their product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders.discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. Their annual meeting is coming up on 6/11/2015. ProxyDemocracy.org had the vote of one fund when I checked and voted on 6/9/2015.  I voted with management 78% of the time and assigned SciClone Pharmaceuticals a proxy score of 78. Continue Reading →

Continue Reading ·

SciClone Pharmaceuticals $SCLN: Proxy Vote

SCLNSciClone Pharmaceuticals $SCLN, is one of the stocks in my portfolio. Their annual meeting is June 12, 2014. ProxyDemocracy.org had collected the votes of one fund when I checked and voted on 6/10/2014.  I voted with management 37% of the time.  View Proxy Statement. Would it kill them to include a hyperlinked table of contents? Read Warnings below. What follows are my recommendations on how to vote the SCLN proxy in order to enhance corporate governance and long-term value.   Continue Reading →

Continue Reading ·

Powered by WordPress. Designed by WooThemes